Additionally, the efficacy of peptides based on the CAV1 scaffolding domain (82DGIWKASFTTFTVTKYWFYR101) in impairing in vitro cancer cell migration [65] and delaying in vivo tumor progression were reported [66]. The gene discussed is CAV1; the disease is neoplasm.